Exchange: OTC·Updated 11:57 AM EDT

PDPHF Egetis Therapeutics AB

$0.6353
$0.00
(0.00%)
Today
EarningsNov 6
Vol40,983.00

About PDPHF

Egetis Therapeutics AB is an innovative and integrated pharmaceutical company, which engages in the development of new drugs for treatment of serious diseases. Its projects include Emcitate for the treatment of patients with monocarboxylate transporter 8 (MCT8) deficiency. The company was founded by Torsten Almén, Heidi Brurok, Louis J. Ignarro, Per Jynge, Jan Olof Gustav Karlsson, Ingemar Lundström, and Rob Towart in 2006 and is headquartered in Stockholm, Sweden.
50

Neutral Sentiment

How do you feel about PDPHF?

Advertisement|Remove ads.